Article Data

  • Views 495
  • Dowloads 131

Original Research

Open Access

Decreased prevalence of high-risk human papillomavirus infection is associated with obesity

  • U. S. Jung1
  • J. S. Choi2,*,
  • J. H. Ko2
  • J. H. Lee3
  • S. Y. Park3
  • S. H. Park4

1Department of Obstetrics and Gynecology, Konyang University Hospital, Konyang University College of Medicine, Daejon

2Department of Obstetrics and Gynecology, Hanyang University College of Medicine, Seoul

3Department of Obstetrics and Gynecology, Sungkyunkwan University School of Medicine, Seoul

4Dr. Park’s Ob & Gyn Clinic, Seoul (Republic of Korea).

DOI: 10.12892/ejgo340113 Vol.34,Issue 1,January 2013 pp.70-74

Published: 10 January 2013

*Corresponding Author(s): J. S. Choi E-mail:


Purpose of investigation: Obesity is correlated with low education, low economic status, and lower rates of Pap smears, which are known as socio-demographic risk factors for cervical cancer. However, the association between obesity and high-risk human papillomavirus (HR-HPV) infection, the necessary cause of cervical cancer, and its related precursors, is not established. Materials and Methods: The authors examined the association between obesity and HR-HPV infection in 6,868 patients, who participated in annual health examinations at the Kangbuk Samsung Hospital in Seoul, Korea, from January through December 2007. Results: The prevalence of HR-HPV infection was 14.8%. Women infected with HR-HPV had a lower body mass index (BMI), when compared with non-infected women. After adjustment for alcohol intake, cigarette smoking, and marital status, HR-HPV infection was found to be negatively associated with BMI. When the analysis was stratified according to BMI, the risk of HR-HPV infection was significantly lower among those who were overweight (OR = 0.817, 95% CI = 0.680 – 0.982), or obese (OR = 0.688, 95% CI = 0.556 – 0.851), when compared with women with normal weight. Conclusion: HR-HPV infection was associated with obesity defined by BMI, with a lower prevalence of infection observed in obese women.


HPV; Obesity; Risk factor; Prevalence

Cite and Share

U. S. Jung, J. S. Choi,J. H. Ko,J. H. Lee,S. Y. Park,S. H. Park. Decreased prevalence of high-risk human papillomavirus infection is associated with obesity. European Journal of Gynaecological Oncology. 2013. 34(1);70-74.


[1] Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al.: “Human papillomavirus is a necessary cause of invasive cervical cancer worldwide”. J. Pathol., 1999, 189, 12.

[2] Sillman F.H., Sentovich S., Shaffer D.: “Ano-genital neoplasia in renal transplant patients”. Ann. Transplant., 1997, 2, 59.

[3] Ferenczy A., Coutlee F., Franco E., Hankins C.: “Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments”. C.M.A.J., 2003, 169, 431.

[4] Shin H.R., Lee D.H., Herrero R., Smith J.S., Vaccarella S., Hong S.H., et al.: “Prevalence of human papillomavirus infection in women in Busan, South Korea”. Int. J. Cancer, 2003, 103, 413.

[5] Steben M., Duarte-Franco E.: “Human papillomavirus infection: epidemiology and pathophysiology”. Gynecol. Oncol., 2007, 107, 5.

[6] Ho G.Y., Bierman R., Beardsley L., Chang C.J., Burk R.D.: “Natural history of cervicovaginal papillomavirus infection in young women”. N. Engl. J. Med., 1998, 338, 423.

[7] Bosch F.X., de Sanjose S.: “The epidemiology of human papillomavirus infection and cervical cancer”. Dis. Markers, 2007, 23, 213.

[8] Kahn J.A., Lan D., Kahn R.S.: “Sociodemographic factors associated with high-risk human papillomavirus infection”. Obstet. Gynecol., 2007, 110, 87.

[9] Winer R.L., Hughes J.P., Feng Q., O`Reilly S., Kiviat N.B., Holmes K.K., et al.: “Condom use and the risk of genital human papillomavirus infection in young women”. N. Engl. J. Med., 2006, 354, 2645.

[10] Rieck G., Fiander A.: “The effect of lifestyle factors on gynaecological cancer”. Best Pract. Res. Clin. Obstet. Gynaecol., 2006, 20, 227.

[11] Wolk A., Gridley G., Svensson M., Nyren O., McLaughlin J.K., Fraumeni J.F., et al.: “A prospective study of obesity and cancer risk (Sweden)”. Cancer Causes Control, 2001, 12, 13.

[12] Moller H., Mellemgaard A., Lindvig K., Olsen J.H.: “Obesity and cancer risk: a Danish record-linkage study”. Eur. J. Cancer, 1994, 30A, 344.

[13] Lacey J.V. Jr., Swanson C.A., Brinton L.A., Altekruse S.F., Barnes W.A., Gravitt P.E., et al.: “Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix”. Cancer, 2003, 98, 814.

[14] Nyholm M., Gullberg B., Haglund B., Rastam L., Lindblad U.: “Higher education and more physical activity limit the development of obesity in a Swedish rural population. The Skaraborg Project”. Int. J. Obes., (Lond) 2008, 32, 533.

[15] Chang V.W., Lauderdale D.S.: “Income disparities in body mass index and obesity in the United States, 1971-2002”. Arch. Intern. Med., 2005, 165, 2122.

[16] Ferrante J.M., Chen P.H., Crabtree B.F., Wartenberg D.: “Cancer screening in women: body mass index and adherence to physician recommendations”. Am. J. Prev. Med., 2007, 32, 525.

[17] Wee C.C., Phillips R.S., McCarthy E.P.: “BMI and cervical cancer screening among white, African-American, and Hispanic women in the United States”. Obes. Res., 2005, 13, 1275.

[18] International Diabetes Institute, WHO Regional Office for the Western Pacific. The Asia-Pacific perspective: Redefining obesity and its treatment. Health Communications Australia Pty Limit: Melbourne, 2000, 56.

[19] Esposito K., Giugliano D.: “Obesity, the metabolic syndrome, and sexual dysfunction”. Int. J. Impot. Res., 2005, 17, 391.

[20] Kirchengast S., Hartmann B., Gruber D., Huber J.: “Decreased sexual interest and its relationship to body build in post-meno - pausal women”. Maturitas, 1996, 23, 63.

[21] Esposito K., Ciotola M., Marfella R., Di Tommaso D., Cobellis L., Giugliano D.: “The metabolic syndrome: a cause of sexual dysfunction in women”. Int. J. Impot. Res., 2005, 17, 224.

[22] Esposito K., Ciotola M., Giugliano F., Bisogni C., Schisano B., Autorino R., et al.: “Association of body weight with sexual function in women”. Int. J. Impot. Res., 2007, 19, 353.

[23] Kolotkin R.L., Binks M., Crosby R.D., Ostbye T., Gress R.E., Adams T.D.: “Obesity and sexual quality of life”. Obesity, 2006, 14, 472.

[24] Brody S.: “Slimness is associated with greater intercourse and lesser masturbation frequency”. J. Sex. Marital. Ther., 2004, 30, 251.

[25] Scott M., Nakagawa M., Moscicki A.B.: “Cell-mediated immune response to human papillomavirus infection”. Clin. Diagn. Lab. Immunol., 2001, 8, 209.

[26] McGlennen R.C.: “Human papillomavirus oncogenesis”. Clin. Lab. Med., 2000, 20, 383.

[27] zur Hausen H.: “Papillomaviruses and cancer: from basic studies to clinical application”. Nat. Rev. Cancer, 2002, 2, 342.

[28] Aggarwal B.B.: “Signalling pathways of the TNF superfamily: a double-edged sword”. Nat. Rev. Immunol., 2003, 3, 745.

[29] Kyo S., Inoue M., Hayasaka N., Inoue T., Yutsudo M., Tanizawa O., et al.: “Regulation of early gene expression of human papillomavirus type 16 by inflammatory cytokines”. Virology, 1994, 200, 130.

[30] Soto U., Das B.C., Lengert M., Finzer P., zur Hausen H., Rosl F.: “Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex”. Oncogene, 1999, 18, 3187.

[31] Fantuzzi G.: “Adipose tissue, adipokines, and inflammation”. J. Allergy Clin. Immunol., 2005, 115, 911.

[32] Naz R.K., Butler A.: “Interleukins-6 and -8 levels in sera and cervical mucus of fertile, idiopathic infertile, and immunoinfertile women: implication in infertility”. Am. J. Reprod. Immunol., 1996, 35, 534.

[33] Naz R.K., Butler A., Witt B.R., Barad D., Menge A.C.: “Levels of interferon-gamma and tumor necrosis factor-alpha in sera and cervical mucus of fertile and infertile women: implication in infertility”. J. Reprod. Immunol., 1995, 29, 105.

[34] Castle P.E., Hildesheim A., Bowman F.P., Strickler H.D., Walker J.L., Pustilnik T., et al.: “Cervical concentrations of interleukin-10 and interleukin-12 do not correlate with plasma levels”. J. Clin. Immunol., 2002, 22, 23.

[35] Ahmed M.I., Salahy E.E., Fayed S.T., El-Hefnawy N.G., Khalifa A.: “Human papillomavirus infection among Egyptian females with cervical carcinoma: relationship to spontaneous apoptosis and TNF-alpha”. Clin. Biochem., 2001, 34, 491.

[36] Song S.H., Lee J.K., Seok O.S., Saw H.S.: “The relationship between cytokines and HPV-16, HPV-16 E6, E7, and high-risk HPV viral load in the uterine cervix”. Gynecol. Oncol., 2007, 104, 732.

[37] Villa L.L., Vieira K.B., Pei X.F., Schlegel R.: “Differential effect of tumor necrosis factor on proliferation of primary human keratinocytes and cell lines containing human papillomavirus types 16 and 18”. Mol. Carcinog., 1992, 6, 5.

[38] Jung W.W., Chun T., Sul D., Hwang K.W., Kang H.S., Lee D.J., et al.: “Strategies against human papillomavirus infection and cervical cancer”. J. Microbiol., 2004, 42, 255.

[39] Dunne E.F., Unger E.R., Sternberg M., McQuillan G., Swan D.C., Patel S.S., et al.: “Prevalence of HPV infection among females in the United States”. JAMA, 2007, 297, 813.

[40] Shin H.R., Franceschi S., Vaccarella S., Roh J.W., Ju Y.H., Oh J.K., et al.: “Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea”. J. Infect. Dis., 2004, 190, 468.

[41] Zhu J., Quyyumi A.A., Norman J.E., Csako G., Waclawiw M.A., Shearer G.M., et al.: “Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels”. Am. J. Cardiol. 2000, 85, 140.

[42] Nabipour I., Vahdat K., Jafari S.M., Pazoki R., Sanjdideh Z.: “The association of metabolic syndrome and Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, and herpes simplex virus type 1: the Persian Gulf Healthy Heart Study”. Cardiovasc .Diabetol., 2006, 5, 25.

[43] Polterauer S., Grimm C., Tempfer C., Sliutz G., Speiser P., Reinthaller A., et al.: “C-reactive protein is a prognostic parameter in patients with cervical cancer”. Gynecol. Oncol., 2007, 107, 114.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time